Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Bruce Simpson
Why ‘people risk’ is jumping to the top of the corporate agenda Original
Opinion: Employees are more important than ever to the success of a company, and leaders are taking notice Author of the article: Dr. Talia Varley, Daniel Moore and Bruce Simpson, Special to Financial Post Published Jun 04, 2024 • Last updated 5 minutes ago • 4 minute read You can save this article by registering for free here. Or sign-in if you have an account. 'People risk' is emerging and evolving topic in risk management.
Making It Back: Bruce Simpson tried to take his own life, then he started healing
Home Magazine Making It Back: Bruce Simpson tried to take… Feature Making It Back: Bruce Simpson tried to take his own life, then he started healing I have practiced law in Kentucky for 40 years, and I write this today to warn you about reaching the point of no return should you ever determine, as I did in January 2023, that death is a better option than life. Yes, I attempted suicide. Now, the facts.
How Companies Can Partner with Nonprofits
Fifteen years ago, if Goldman Sachs went looking for financial advice, a small, green nonprofit might be the last place it looked. Today, the firm and a host of other Wall St. giants don’t think twice about partnering with JUST Capital, a nonprofit that provides third-party data, tools, and insights to help measure and improve corporate performance on stakeholder and ESG issues.
Startups Need an ESG Strategy
Over the last five years, the corporate world has focused increasingly on implementing stakeholder capitalism through Environmental, Social and Governance principles (ESG). However, is ESG a distraction to cash-strapped talent and time constrained startups? Should founders build their business first and worry about ESG later?
01.13.22 -- Inside The Human Virome & Next-Gen Gene Therapy Vectors
Article | By Bruce C. Simpson, Thermo Fisher Scientific The most common storage is ultra-low temperature storage, but the fastest growing is cryogenic, in vapor phase liquid nitrogen. This transition is huge. Chain of temperature and custody data is imperative.
01.04.22 -- 4 Ways AI Is Changing The Future Of Precision Medicine
Article | By Bruce C. Simpson, Thermo Fisher Scientific Due to the complexity and temperature sensitivity of biologics, we're seeing an increase in nontraditional storage temperature requests. Here, we explore why this is occurring and the associated challenges.
09.21.21 -- 6 Steps For Cell Therapy Clinical Development Success
Article | By Joe Arcangelo, inSeption Group No matter how brilliant a clinical trial process or a technology may be, it is useless without skilled, motivated individuals at the helm. Article | By Bruce C. Simpson, Thermo Fisher Scientific Due to the complexity and temperature sensitivity of biologics, we're seeing an increase in nontraditional storage temperature requests. Here, we explore why this is occurring and the associated challenges.
08.17.21 -- Decoding The Immune Synapse To Create Novel Immunotherapies
Newsletter | August 17, 2021 By Anthony J. Coyle, Ph.D., Repertoire Immune Medicines The potential of T-cell therapies to be curative by harnessing our own immune repertoire has exciting implications for cancer and many other immune-mediated disorders. By Erin Harris, editor in chief, Cell & Gene Many effective treatments for multiple myeloma exist, but it is currently incurable.
05.13.21 -- Biopharma Cold Chain Logistics 101
Newsletter | May 13, 2021 By Curtis Gippe, Adept Packaging Cold chain logistics can be complex and intricate. Maintaining the integrity of controlled-temperature products requires holistic consistency between design and development, manufacturing and packaging, qualification and validation, cold storage, transportation, and monitoring as the product moves from its point of origin to the end user.
05.10.21 -- Manufacturing Therapeutics In Hospitals: Re-Envisioning The Bioprocessing Paradigm
Article | By Bruce C. Simpson, Thermo Fisher Scientific Due to the complexity and temperature sensitivity of biologics, we're seeing an increase in nontraditional storage temperature requests. Here, we explore why this is occurring and the associated challenges. Article | By Lisa Cherry, Ph.D., Pfizer CentreOne Changes in raw materials are inevitable over a drug's lifespan, but even small modifications can throw your drug out of compliance.
Letter: Bruce Simpson
Seattle’s school openings offer lessons for Yakima To the editor — Kids in classrooms. It appears that Seattle schools are welcoming students back to classrooms in grades six through 12. This is happening by having some of the students go in the morning and the rest in the afternoon. This will create some challenges for some of the parents and school personnel but should be more than offset by the benefits to the students.
03.25.21 -- A Major Drilldown Into BioPhorum's CGT Process Maps
Article | By Bruce C. Simpson, Thermo Fisher Scientific Due to the complexity and temperature sensitivity of biologics, we're seeing an increase in nontraditional storage temperature requests. Here, we explore why this is occurring and the associated challenges.
Purpose for asset owners: Climbing a taller mountain
In the wake of the pandemic, the world’s long-term investors are reexamining their purpose. The world’s pension funds, sovereign-wealth funds, and endowments are no strangers to purpose—they intentionally strive to create positive societal impact. After all, they have long been using purpose as a not-so-secret weapon to attract talent while competing with higher-paying private-sector investment managers.
01.11.21 -- The AAV Vector Challenge With Selecta's Dr. Carsten Brunn
Article | By Bruce C. Simpson, Thermo Fisher Scientific The most common storage is ultra-low temperature storage, but the fastest growing is cryogenic, in vapor-phase liquid nitrogen. This transition is huge. Chain of temperature and custody data is imperative. Article | By Martin Gonzalez, Ph.D., Pfizer CentreOne Contract Manufacturing This is the first installment in a three-part series that examines the causes of protein aggregation and practical steps you can take to mitigate the risk.
12.16.20 -- Human Performance In Biopharma -- Your Problem Isn't Error
A conversation with John Wilkes (AstraZeneca), Clifford Berry (Takeda), Amy D. Wilson, Ph.D. (Biogen), and Jim Morris (NSF Health Sciences) Part 1 of a two-part roundtable discusses key drivers for human performance improvement, lean manufacturing and human performance programs, and perspectives on human performance in the context of the rapid scale-up and production of COVID-19 therapeutics and vaccines.
Purpose, not platitudes: A personal challenge for top executives
Imagine you are a CEO making the difficult decision to furlough frontline workers during the COVID-19 pandemic. While the decision weighs heavily on you, you know that furloughs are preferable to layoffs.
Purpose vs PR: how business can find meaning in the COVID-19 era
About this McKinsey Live event For many organizations, the events of 2020 have brought “purpose” urgently to the foreground. But what does it really mean, how does it affect company performance, and how do leaders ensure that their commitment to purpose goes beyond lip service?
11.17.20 -- Human Performance In Biopharma Operations -- Your Problem Isn't Error
A conversation with John Wilkes (AstraZeneca), Clifford Berry (Takeda), Amy D. Wilson, Ph.D. (Biogen), and Jim Morris (NSF Health Sciences) This is Part 1 of a two-part roundtable Q&A focused on human performance in pharmaceutical operations.
The case for stakeholder capitalism
The free-market economy is one of the most important reasons for the wealth creation and improved quality of life humanity has enjoyed in recent generations. In 1950, for example, Norway had the world’s highest life expectancy (72.3 years). Now the global average is higher (72.6 years) and in Africa, where it is lowest, it is rising fastest.
Purpose, or ‘purpose- washing’? A crossroads for business leaders
Business is changing. A powerful mix of forces—employee activism, enhanced media transparency, government gridlock, and proliferating global problems such as the COVID-19 pandemic, rising inequality, and climate change—have led an ever-growing group of corporate leaders to recognize that a focus on profit is not enough. Purpose beyond profit has become a necessary ingredient for exceptional business success. But how do you inject purpose into a business?
InsurTechs provide the COVID-19 perspective carriers need now
Insurance companies have an opportunity to join together to innovate and find new solutions. (Photo: Shutterstock) The COVID-19 pandemic has tested businesses and industries across the world in ways never before seen. The insurance community, an industry that was built upon the principle of helping citizens and businesses in vulnerable times, is facing a new suite of challenges.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Bruce
Contact Bruce, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack